Live Breaking News & Updates on Zandu Chemicals

Stay updated with breaking news from Zandu chemicals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Parikh family sells ZCL Chemicals to Advent for Rs 2K cr


Parikh family sells ZCL Chemicals to Advent for Rs 2K cr
​ By
IANS
|
Published on
​ Thu, Mar 11 2021 16:57 IST
|
​ 0 Views
Rupees.. Image Source: IANS News
New Delhi, March 11 : The Parikh family, founder and promoter of ZCL Chemicals Limited (ZCL), announced on Thursday that it has sold the entire stake in the company to Advent International, one of the largest private equity investors, for an equity value of Rs 2,000 crore.
Pusuant to the signing of definitive agreements last month, the Parikh family sold its entire 80 per cent holding to completely exit ZCL. Of the above, 26 per cent will be transferred subject to the customary closing conditions and receipt of all applicable regulatory approvals. ....

New Delhi , Nihar Parikh , Zandu Pharmaceuticals , Zandu Chemicals , Advent International , Chemicals Limited , Stanley Private Equity Asia , Zandu Chemicals Limited , Zandu Pharmaceuticals Limited , புதியது டெல்ஹி , நிஹார் பாறிக் , ஜந்து மருந்துகள் , ஜந்து இரசாயனங்கள் , இரசாயனங்கள் வரையறுக்கப்பட்டவை , ஸ்டான்லி ப்ரைவேட் பங்கு ஆசியா , ஜந்து இரசாயனங்கள் வரையறுக்கப்பட்டவை , ஜந்து மருந்துகள் வரையறுக்கப்பட்டவை ,

Zandu Chemicals Limited sold to Advent for Rs 2000 cr


Zandu Chemicals Limited sold to Advent for Rs 2000 cr
By IANS|   Updated: 11th March 2021 6:13 pm IST
New Delhi: The Parikh family, founder and promoter of ZCL Chemicals Limited (ZCL), announced on Thursday that it has sold the entire stake in the company to Advent International, one of the largest private equity investors, for an equity value of Rs 2,000 crore.
Pusuant to the signing of definitive agreements last month, the Parikh family sold its entire 80 per cent holding to completely exit ZCL. Of the above, 26 per cent will be transferred subject to the customary closing conditions and receipt of all applicable regulatory approvals. ....

New Delhi , Nihar Parikh , Zandu Pharmaceuticals , Zandu Chemicals , Advent International , Chemicals Limited , Stanley Private Equity Asia , Zandu Chemicals Limited , Zandu Pharmaceuticals Limited , Siasat Daily , புதியது டெல்ஹி , நிஹார் பாறிக் , ஜந்து மருந்துகள் , ஜந்து இரசாயனங்கள் , இரசாயனங்கள் வரையறுக்கப்பட்டவை , ஸ்டான்லி ப்ரைவேட் பங்கு ஆசியா , ஜந்து இரசாயனங்கள் வரையறுக்கப்பட்டவை , ஜந்து மருந்துகள் வரையறுக்கப்பட்டவை ,

How Nihar Parikh created the ₹2,000-cr ZCL Chemicals in 12 years


On Tuesday, private equity firm Advent International acquired the entire stake in the company
In 2008, when FMCG major Emami Group took over Zandu Pharmaceuticals from Mumbai-based Parikh family, 22-year-old Nihar Parikh decided to buyback Zandu Chemicals, a subsidiary, and carve it out into a separate firm. Little did he know that his initial investment of ₹12.5 crore would multiply 160 times to fetch him a whopping ₹2,000 crore in just 12 years.
On Tuesday, private equity firm Advent International acquired the entire stake in ZCL Chemicals Ltd (formerly known as Zandu Chemicals Ltd) for about ₹2,000 crore, a move that also marked the exit of Morgan Stanley Private Equity Asia (MSPEA), which also sold its 19 per cent stake in the company. ....

Satish Khanna , Ajay Parikh , Nihar Parikh , Chemicals Ltd , Zandhu Pharmaceuticals , Zandu Pharmaceuticals , Us Food Drug Administration , Emami Group , Advent International , Zandu Chemicals Ltd , Mumbai Based Parikh , Zandu Chemicals , Morgan Stanley Private Equity Asia , Drug Administration , Manufacturing Practices , Zandu Chemical , Mumbai Based Lupin , Zcl Chemicals , சத்தீஷ் கண்ணா , அஜய பாறிக் , நிஹார் பாறிக் , இரசாயனங்கள் லிமிடெட் , ஜந்து மருந்துகள் , ஜந்து இரசாயனங்கள் லிமிடெட் , மும்பை அடிப்படையிலானது பாறிக் , ஜந்து இரசாயனங்கள் ,

Advent International acquires majority stake in ZCL Chemicals


Advent International acquires majority stake in ZCL Chemicals
Advent International acquires majority stake in ZCL Chemicals
10 February 2021 | News
ZCL is one of the fastest growing manufacturers of specialty active pharmaceutical ingredients (APIs) and advanced intermediates
Source credit: Shutterstock
Advent International, one of the largest and most experienced global private equity investors, announced that it has signed a definitive agreement to acquire a majority stake in ZCL Chemicals Limited, one the fastest growing pharmaceutical companies in India. The business was formerly known as Zandu Chemicals Ltd.
With this transaction, Morgan Stanley Private Equity Asia (MSPEA), a private equity platform that previously managed a minority investment in ZCL, will exit their investment. ....

Pankaj Patwari , Shweta Jalan , Nihar Parikh , Chemicals Ltd , Advent International India , Advent International , Zandu Chemicals Ltd , Zandu Chemicals , Morgan Stanley Private Equity Asia , Managing Director , Executive Director , Sole Financial Advisor , Bombay Law Chambers , Legal Counsel , Zcl Chemicals Limited , பங்கஜ் பட்வாரி , ஷுவேத் ஜலான் , நிஹார் பாறிக் , இரசாயனங்கள் லிமிடெட் , ஜந்து இரசாயனங்கள் லிமிடெட் , ஜந்து இரசாயனங்கள் , மோர்கன் ஸ்டான்லி ப்ரைவேட் பங்கு ஆசியா , நிர்வகித்தல் இயக்குனர் , நிர்வாகி இயக்குனர் , குண்டு சட்டம் அறைகள் , சட்டப்பூர்வமானது ஆலோசனை ,